Indefinite Delivery Contract 75D30120D07517
Award Date
4/1/20
Last Date to Order
3/31/21
Federal Agency
CDC Pittsburgh
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Contract (IDC) worth up to $13,017,750 to Grifols USA LLC for the provision of various pediatric vaccines. The contract has an ultimate completion date of March 31, 2023 and was awarded on April 1, 2022 without any set-aside designations, indicating Grifols' capability as a large business to fulfill substantial federal vaccine requirements. The IDC supports the CDC's Vaccines for Children program and other...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Grifols USA LLC, a global healthcare company and manufacturer of essential plasma-derived medicines and vaccines. The contract, valued at a ceiling of $12,409,500, is for the supply of 20 standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under the Vaccines for Children 2021 program to support pediatric immunization efforts. The contracts hold a potential value of $1.039 billion and were awarded to Glaxosmithkline, LLC for the period of April 1, 2021 through March 31, 2022. The contracts will provide 20 standard pediatric vaccines to the CDC's Immunization Awardees for distribution through the Vaccines for Children program and Section...
The Centers for Disease Control and Prevention (CDC) awarded a $1,727,800 indefinite delivery contract to Grifols USA LLC, a global healthcare company, to purchase 12 standard adult vaccines. The contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and is not designated with any set-aside provisions. The vaccines are required to have a minimum 12-month shelf life and be delivered within 15 business days of order. The vaccines will support CDC immunization awardees,...
The Centers for Disease Control and Prevention awarded Grifols USA LLC an indefinite delivery contract for 2019 adult vaccines. The multiple award IDC has a potential value of $1,602,700 and a period of performance from July 1, 2019 through June 30, 2020. Grifols will supply various adult vaccines to support public health programs through the CDC. As a manufacturer of pharmaceuticals and medical products, Grifols has extensive experience providing specialized drugs, vaccines, immunoglobulins and...
This federal contract IDV award was issued by the Centers for Disease Control and Prevention (CDC) to procure pediatric vaccines for the Vaccines for Children (VFC) program. The 5-year, $1.35 billion multiple award contract aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The prime contractor,...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, provides for the purchase of 20 different pediatric vaccines for the CDC's Vaccines for Children program. The contract has a $986,824,450 ceiling value and a period of performance from April 1, 2020 through March 31, 2021. Glaxosmithkline, as the prime contractor, will supply vaccines such as DTaP, Hep A and B, Hib, HPV, MMR, pneumococcal, rotavirus, and varicella in...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella vaccines....
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide up to 23 standard pediatric vaccines. The $1.14 billion, multiple-award contract has a period of performance from April 1, 2022 to March 31, 2023 and supports pediatric immunization programs under Section 317(j) of the Public Health Service Act and the Vaccines for Children program. The vaccines, which must have a minimum...
The Centers for Disease Control and Prevention (CDC) has awarded an Indefinite Delivery Contract (IDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of up to 23 standard pediatric vaccines. The $3.301 billion contract will run from April 1, 2022 through March 31, 2023, supporting the CDC's Immunization Awardees and the Vaccines for Children program under Section 317(j) of the Public Health Service Act. The vaccines being procured include a wide range such as DTaP, Hep...